首页> 外文OA文献 >Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

【2h】

Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

机译：第1阶段临床试验设计的方法侧重于安全，效率和选定的患者人群：国家癌症研究所调查委员会临床试验设计工作队的报告

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. Percy Ivy; Lillian L. Siu; Elizabeth Garrett-Mayer; Larry Rubinstein;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. [J] . Ivy SP, Siu LL, Garrett Mayer Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第6期

机译：阶段1临床试验设计的方法侧重于安全性，效率和选定的患者人群：国家癌症研究所研究药物指导委员会临床试验设计工作组的报告。
2. The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee. [J] . Seymour L, Ivy SP, Sargent Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第6期

机译：测试癌症治疗剂的II期临床试验的设计：来自美国国家癌症研究所研究药物指导委员会的临床试验设计工作组的共识性建议。
3. Design of phase I combination trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee [J] . PallerC.J., BradburyP.A., IvyS.P., Clinical cancer research: an official journal of the American Association for Cancer Research . 2014,第16期

机译：一期联合试验的设计：NCI研究药物指导委员会临床试验设计工作组的建议
4. DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS [C] . NOPHARGEIFMAN, ATUL J.BUTTE Pacific Symposium on Biocomputing . 2016

机译：癌症临床试验群体真正代表癌症患者吗？对癌症基因组阿特拉斯公开临床试验的比较
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Approaches to Phase 1 Clinical Trial Design Focused on Safety Efficiency and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee [O] . S. Percy Ivy, Lillian L. Siu, Elizabeth Garrett-Mayer, -1

机译：途径1期临床试验设计方面的安全效率和选择的患者人群：从美国国家癌症研究所调查药物指导委员会的临床试验设计工作组报告
7. Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee [O] . Channing J. Paller, Penelope A. Bradbury, S. Percy Ivy, 2014

机译：阶段综合试验设计：NCI调查药指导委员会临床试验设计工作队的建议
8. Report of the Operational Efficiency Working Group of the Clinical Trials and Translational Research Advisory Committee: Compressing the Timeline for Cancer Clinical Trial Activation [R] . 2010

机译：临床试验和转化研究咨询委员会运作效率工作组的报告：压缩癌症临床试验激活的时间表

Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

著录项

引文网络

相似文献

相关主题

期刊订阅